March 18, 2023 11:34 AM
Latest:
  • Volkswagen Strategizes Mine Investments In Effort to Reduce EV Battery Costs
  • Donald Trump Claims He Will Be Arrested On Tuesday, Calls For Protest
  • Banksplaining: The Dive Draws About How Money Works (and doesn’t) Part 1: Reserve Ratios
  • Not Bats, But Raccoons Could’ve Started The COVID-19 Pandemic – Experts
  • US Bailout of SVB Will Include Chinese Communist Party-Linked Depositors
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Bright Minds Biosciences

Briefing News Psychedelics 

Bright Minds Begins Phase 1 Clinical Trials Focused On Treating Dravet Syndrome

August 31, 2022 8:52 AMAugust 31, 2022 8:52 AM Jay Lutz 0 Comments Bright Minds Biosciences

Phase 1 trials are officially underway for Bright Minds Biosciences (CSE: DRUG) and their lead product, referred to as BMB-101.

Share
Tweet
Share
Read more
Biotech Briefing News 

Bright Minds Biosciences Looks To Raise $4.0 Million Via Overnight Offering

August 24, 2022 8:40 AMAugust 24, 2022 8:40 AM Jay Lutz 0 Comments Bright Minds Biosciences

After several days of intense volatility, Bright Minds Biosciences (CSE: DRUG) is looking to capitalize on the sudden investor interest.

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds Moves Into Clinical Development Stage Following Positive Toxicity Results

March 14, 2022 7:54 AMMarch 14, 2022 7:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Drug development continues for the Bright Minds Biosciences (CSE: DRUG) lead product. The firm this morning published positive results from

Share
Tweet
Share
Read more
Briefing Full Analysis Psychedelics Video Series 

Bright Minds Bioscience: A Deep Dive

December 2, 2021 1:30 PMDecember 3, 2021 8:16 AM Jay Lutz 0 Comments Bright Minds Biosciences

Today we are diving into a firm focused on mental health, whom is also a recently Nasdaq-listed Psychedelic Stock, Bright

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds Bioscience Approved For Nasdaq Listing

November 3, 2021 8:50 AMNovember 3, 2021 8:50 AM Jay Lutz 1 Comment Bright Minds Biosciences

There’s another Canadian firm set to trade on the Nasdaq market. Bright Minds Bioscience (CSE: DRUG) this morning announced that

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds Biosciences Advances Lead Serotonergic Drug Candidate To Toxicology Studies, Targets Human Trials In 2022

September 22, 2021 3:24 PMSeptember 22, 2021 2:48 PM ER Velasco 0 Comments Bright Minds Biosciences

Bright Minds Biosciences (CSE: DRUG) shared today scientific updates regarding its serotonergic drug pipeline. This includes the announcement of advancing

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds: Eight Capital Assigns $11.50 Price Target To Firm

September 20, 2021 10:09 AMSeptember 19, 2021 10:08 PM Justin Young 0 Comments Analyst Estimate, Bright Minds Biosciences

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer

Share
Tweet
Share
Read more
Briefing Psychedelics Video Series 

Explainer: Anti Alzheimer’s, Dravet Syndrome, Epilepsy & Addiction Drugs – The Daily Dive

September 10, 2021 1:30 PMSeptember 10, 2021 1:15 PM Jay Lutz 0 Comments Bright Minds Biosciences, Ian McDonald, The Daily Dive

On today’s Daily Dive, Cassandra welcomes back Ian McDonald, CEO of Bright Minds Biosciences (CSE: DRUG). He shares the promising

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Bright Minds Biosciences Proprietary Compound Shows Reduction Of Seizures In Pre-Clinical Studies

August 18, 2021 8:54 AMAugust 18, 2021 8:54 AM Jay Lutz 0 Comments Bright Minds Biosciences

Bright Minds Biosciences (CSE: DRUG) this morning announced preliminary results from an ongoing study being conducted by the firm. The

Share
Tweet
Share
Read more
Briefing Psychedelics Video Series 

Bright Minds: Focusing On Second Generation Psychedelic Compounds – The Daily Dive

June 21, 2021 1:30 PMJune 21, 2021 11:57 AM Jay Lutz 0 Comments Bright Minds Biosciences, Gideon Shapiro, The Daily Dive

Starting off this week on the Daily Dive is that of Dr Gideon Shapiro, whom is VP of Discovery at

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Volkswagen Strategizes Mine Investments In Effort to Reduce EV Battery Costs
Automotive Briefing 

Volkswagen Strategizes Mine Investments In Effort to Reduce EV Battery Costs

March 18, 2023 11:14 AM Hermina Paull 0

Volkswagen has unveiled intentions to invest in mining operations, in an effort to eventually cut back on costs associated with

Donald Trump Claims He Will Be Arrested On Tuesday, Calls For Protest
Briefing Macro 

Donald Trump Claims He Will Be Arrested On Tuesday, Calls For Protest

March 18, 2023 9:29 AM Jay Lutz 0
Banksplaining: The Dive Draws About How Money Works (and doesn’t) Part 1: Reserve Ratios
Bonds Briefing Education 

Banksplaining: The Dive Draws About How Money Works (and doesn’t) Part 1: Reserve Ratios

March 18, 2023 9:00 AM Braden Maccke 0
Not Bats, But Raccoons Could’ve Started The COVID-19 Pandemic – Experts
Briefing Healthcare 

Not Bats, But Raccoons Could’ve Started The COVID-19 Pandemic – Experts

March 17, 2023 3:09 PM ER Velasco 0
US Bailout of SVB Will Include Chinese Communist Party-Linked Depositors
Briefing Macro 

US Bailout of SVB Will Include Chinese Communist Party-Linked Depositors

March 17, 2023 2:18 PM JP Alegre 0
Carlyle Commodities: Early Results At The Newton Project — With Morgan Good
Briefing Resources Video Series 

Carlyle Commodities: Early Results At The Newton Project — With Morgan Good

March 17, 2023 1:30 PM Jay Lutz 0
San Francisco Bay Area to Ban Natural Gas Heating Appliances by 2027
Briefing Energy 

San Francisco Bay Area to Ban Natural Gas Heating Appliances by 2027

March 17, 2023 12:47 PM JP Alegre 0

Spotlight Series

Carlyle Commodities: Early Results At The Newton Project — With Morgan Good
Briefing Resources Video Series 

Carlyle Commodities: Early Results At The Newton Project — With Morgan Good

March 17, 2023 1:30 PM Jay Lutz 0

Joining us today on the Daily Dive is Morgan Good, CEO of Carlyle Commodities Corp (CSE: CCC). Morgan sits down

News

Eguana Sees ITOCHU Increase Stake To 12.95%
Briefing News Technology 

Eguana Sees ITOCHU Increase Stake To 12.95%

March 16, 2023 9:00 AM Jay Lutz 0

Eguana Technologies (TSXV: EGT) this morning is reporting that one of its largest shareholders has increased its stake in the

Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold
Briefing News Resources 

Carlyle Commodities Hits 689 Metres Of 0.51 g/t Gold

March 15, 2023 10:06 AM Jay Lutz 0
First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry
Briefing News Resources 

First Phosphate: New Report Suggests Flagship Property Holds ESG-Compliant Source Of Phosphate For LFP Battery Industry

March 14, 2023 11:22 AM Jay Lutz 0
Trillion Energy Hits 55 Metres Of Potential Gas Pay In Fourth Well At SASB
Briefing Energy News 

Trillion Energy Hits 55 Metres Of Potential Gas Pay In Fourth Well At SASB

March 14, 2023 10:03 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.